Skip to main content

Public Health - Epidemiology

Crisaborole and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis: a Public Health Approach

Alejandra Puerta, Dept. of Public Health, Epidemiology Division, New York Medical CollegeFollow
Elizabeth Drugge PhD, MPH, Dept. of Public Health, Epidemiology Division, New York Medical CollegeFollow
Ellen Loh BSPharm, MBA, PhD, Touro School of Pharmacy, New York, NYFollow

Start Date

4-2020 12:00 AM

Description

We conducted a literature review to explore the effect of Crisaborole on patient QoL associated with mild to moderate atopic dermatitis.

Request Accessible Format
Need this file in a format that works better with assistive technology? Submit a request.

Included in

Clinical Epidemiology Commons, Epidemiology Commons, Other Public Health Commons, Public Health Education and Promotion Commons

COinS

Apr 1st, 12:00 AM

Crisaborole and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis: a Public Health Approach

We conducted a literature review to explore the effect of Crisaborole on patient QoL associated with mild to moderate atopic dermatitis.